Moneycontrol.com, India -... Zydus Cadila had, through its subsidiaries, acquired 100 per cent stake in Nippon Universal Pharmaceuticals Ltd for an undisclosed consideration in ...<br><img src="/images/chart_7777cc3.gif" class="ticker-icon" width="14" height="12"><a href="http://finance.google.com/finance?q=BOM:532321&client=news" class="rich">BOM:532321</a><a href="http://www.journalnow.com/servlet/Satellite?pagename=WSJ%2FMGArticle%2FWSJ_BasicArticle&c=MGArticle&cid=1173352155081&path=!localnews&s=1037645509099" id=r-2_1118542323>Diabetes drugs may increase risk</a><br>Winston-Salem Journal (subscription), NC - 57 minutes ago<br>Actos is made by Takeda Pharmaceuticals, based in Deerfield, Ill. Takeda declined yesterday through a spokesman to comment on the Wake Forest study until ...

::Read the Full Article